Natural history and etiology of liver disease in patients with previous community-acquired acute non-A, non-B hepatitis. A follow-up study of 178 Danish patients consecutively enrolled in The Copenhagen Hepatitis Acuta Programme in the period 1969-1987

Journal of Hepatology

Volumn 31, Issue 5, 1999, Pages 800-807

  Grønbæk, Karin ^f   Krarup, Henrik Bygum ^b   Møller, Henrik ^c   Krogsgaard, Kim ^d   Franzmann, Maria ^d   Sonne, Jesper ^a   Ring Larsen, Helmer ^e   Dietrichson, Odd ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Centre for Research in Health and Social Statistics   (Denmark)

^d Mental Health Services CPH   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f C   (Denmark)

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis C; Non A; Non B hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLISM; ANTIBODY PRODUCTION; ARTICLE; CAUSE OF DEATH; CHRONIC HEPATITIS; DENMARK; DISEASE COURSE; DRUG INTOXICATION; FEMALE; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; VIREMIA;

EID: 0032696618     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80280-3     Document Type: Article

References (38)

1. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 14:1991;969-974.
2. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med. 327:1992;1906-1911.
3. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol. 16:1992;273-281.
4. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, et al. Persistent hepatitis C viraemia after acute self-limiting post-transfusion hepatitis C. Hepatology. 21:1995;639-644.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.
6. Mattsson L, Sönnerborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver. 13:1993;274-278.
7. Christensen PB, Grønbæk K, Krarup HB. Transfusion-acquired hepatitis C: the Danish lookback experience. Transfusion. 39:1999;188-193.
8. Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol. 27:1992;812-816.
9. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol. 88:1993;240-243.
10. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 332:1995;1463-1466.
11. Nielsen JO. Australia antigen ved akutte og kroniske leversygdomme. University of Copenhagen, FADL's Forlag. 1974.
12. Dietrichson O. Kronisk hepatitis. Klassifikation, ætiologi, patogenese, og prognose belyst ved kliniske, serologiske og morfologiske studier. University of Copenhagen, FADL's Forlag. 1977.
13. Mathiesen LR. The hepatitis A virus infection. University of Copenhagen. Liver. 1:1981;81-109.
14. Skinhøj P. Epidemiological aspects of viral hepatitis A and B infections. University of Copenhagen, FADL's Forlag. 1981.
15. Aldershvile J. Hepatitis B e antigen and antibody. University of Copenhagen, FADL's Forlag. 1983.
16. Tage-Jensen U. Levermembranantistof (LKM) og andre autoantistoffer bestemt ved immunfluorescensteknik hos patienter med leversygdomme. University of Copenhagen. Black-print. 1983.
17. Kryger P. Non-A, non-B hepatitis. Serological, clinical, morphological and prognostic aspects. University of Copenhagen. Liver. 3:1983;176-198.
18. Schlicting P. Chronic aggressive hepatitis and active cirrhosis. Morphology, prognosis and therapy. University of Copenhagen, Eget forlag. 1984.
19. Krogsgaard K. Hepatitis B virus DNA in serum. Applied molecular biology in the evaluation of hepatitis B infection. Liver. 8:1988;257-283.
20. Kryger P, Christoffersen P, Aldershvile J, Mathiesen LR, Nielsen JO, Tage-Jensen U, et al. The long-term prognosis of non-transfusion associated non-A, non-B hepatitis. A clinical, epidemiological and histological investigation. Scand J Gastroenterol. 18:1983;519-527.
21. Sørensen TIA. Skinhøj P and menbers of the Copenhagen Hepatitis Acuta Programme. Mortality after acute hepatitis type A, B, and non-A, non-B in 981 patients followed up for up to 10 years. Scand J Gastroenterol. 17:1982;193-198.
22. Krogsgaard K, Wantzin P, Mathiesen LR, Sonne J, Ring-Larsen H. The Copenhagen Hepatitis Acuta Programme. Early appearance of antibodies to hepatitis C virus in community acquired acute non-A, non-B hepatitis is associated with progression to chronic liver disease. Scand J Infect Dis. 22:1990;399-402.
23. Poulsen H, Christoffersen P. Atlas of Liver Biopsies. Copenhagen: Munksgaard. 1979.
24. Mathiesen LR, Fauerholdt L, Møller AM, Aldershvile J, Dietrichson O, Hardt F, et al. Immunoflurescence studies for hepatitis A virus and hepatitis B surface and core antigen in liver biopsies from patients with acute viral hepatitis. Gastroenterology. 77:1979;623-628.
25. Møller AM, Mathiesen LR. Detection of immunoglobulin M antibodies to hepatitis A virus by enzyme-linked immunosorbent assay. J Clin Microbiol. 10:1979;628-632.
26. Mathiesen LR, Feinstone SM, Wong DC, Skinhøj P, Purcell RH. Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol. 7:1978;184-193.
27. Kryger P, Mathiesen LR, Møller AM, Aldershvile J, Hansson BG, Nielsen JO. Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen. J Clin Microbiol. 13:1981;405-409.
28. Kryger P, Aldershvile J, Mathiesen LR, Nielsen JO. Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM. Hepatology. 2:1982;50-53.
29. Døssing M, Poulsen HE, Andreasen PB, Tygstrup N. A simple method for determination of antipyrine clearance. Clin Pharmacol Ther. 32:1982;392-396.
30. Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Lab Invest. 58:1998;1-8.
31. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
32. Persico M, Romano M. Alanine aminotransferase measurements and histological disease in hepatitis C. Lancet. 342:1993;1369-1370.
33. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med. 115:1991;443-449.
34. Irving WL, Neal KR, Underwood JCE, Simmonds PN, James V. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. BMJ. 308:1994;695-696.
35. Grønbæk K, Jensen JO, Krarup HB, Dietrichson O. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus. Dan Med Bull. 43:1996;186-188.
36. Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. QJM. 86:1993;119-125.
37. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 29:1999;908-914.
38. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 349:1997;825-832.